US RESEARCH suggests that a personal continuous glucose monitor (CGM) workflow led by a pharmacist could significantly improve outcomes in patients with diabetes.
The research was published in the Journal of the American Pharmacists Association, and the authors said it demonstrates the importance of pharmacists in medical care teams.
"The available data signify that use of CGMs improves diabetes management and minimises the risk of hypoglycaemic events," the authors wrote.
"Despite increased use, follow-up with patients who use personal CGMs is a challenge in primary care settings.
"The lack of personnel to download and interpret results combined with the lack of time to review results creates challenges to maximize the benefits of CGM therapy and implement indicated medication changes," they added.
The study set out to evaluate a pharmacist-led personal CGM workflow and its impact on glycaemic management in patients with diabetes.
It included a medical care team consisting of two medical doctors, five physician assistants, two nurse practitioners and one clinical pharmacist.
As part of the CGM workflow, pharmacists conducted an initial chart review, reviewed patient CGM data and implemented any indicated therapy changes.
The main outcome considered, HbA1c, decreased to an average 7.1% from a baseline average of 8.3% after the implementation of the CGM workflow.
Read the full paper HERE.
The above article was sent to subscribers in Pharmacy Daily's issue from 13 Jan 25
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 13 Jan 25
